Fast Five Quiz: Are You Prepared to Confront Metastatic Breast Cancer?

Winston W. Tan, MD

December 21, 2021

Systemic disease treatments are used to prolong survival and improve quality of life. Single-agent sequential cytotoxic therapy is preferred in the setting of metastatic breast cancer. Combination cytotoxic therapy is associated with a higher response rate, but toxicities are also increased, and it confers no survival benefit. Chemotherapy is used in patients with resistance to endocrine therapy or ER/PR-negative disease and a moderate or high disease burden.

Discover highlights from ASCO 2021 on the management of metastatic breast cancer here.

Learn more about the treatment and management of metastatic breast cancer.

Editor's Recommendations

1 2 3 4 5 6

Next Section

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Fast Five Quiz: Are You Prepared to Confront Metastatic Breast Cancer? - Medscape - Dec 21, 2021.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....

Need a Curbside Consult? Share cases and questions with Physicians on Medscape Consult. Share a Case

Fast Five Quiz: Are You Prepared to Confront Metastatic Breast Cancer?

Tables

Authors and Disclosures

Authors and Disclosures

Author

Winston W. Tan, MD

Comments

Email This

Feedback

Confirm

Update